BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35648714)

  • 1. Thyroidectomy without Radioiodine in Low-Risk Thyroid Cancer.
    Tulchinsky M
    N Engl J Med; 2022 Jun; 386(22):2153-2154. PubMed ID: 35648714
    [No Abstract]   [Full Text] [Related]  

  • 2. Thyroidectomy without Radioiodine in Low-Risk Thyroid Cancer.
    Gulec SA; McGoron AJ
    N Engl J Med; 2022 Jun; 386(22):2154-2155. PubMed ID: 35648716
    [No Abstract]   [Full Text] [Related]  

  • 3. Thyroidectomy without Radioiodine in Low-Risk Thyroid Cancer.
    Greenspan BS
    N Engl J Med; 2022 Jun; 386(22):2154. PubMed ID: 35648715
    [No Abstract]   [Full Text] [Related]  

  • 4. Thyroidectomy without Radioiodine in Low-Risk Thyroid Cancer. Reply.
    Leboulleux S; Schlumberger MJ; Borget I
    N Engl J Med; 2022 Jun; 386(22):2155. PubMed ID: 35648717
    [No Abstract]   [Full Text] [Related]  

  • 5. Commentary: Application of post-surgical stimulated thyroglobulin for radioiodine remnant ablation selection in low-risk papillary thyroid carcinoma.
    Terris DJ
    Head Neck; 2010 Jun; 32(6):698-9. PubMed ID: 20187017
    [No Abstract]   [Full Text] [Related]  

  • 6. [Radioiodine in the treatment of generalized papillary and follicular thyroid carcinoma].
    Mäenpää H
    Duodecim; 2014; 130(6):573-9. PubMed ID: 24724456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Total thyroidectomy without radioiodine ablation for low-risk thyroid cancer].
    Dralle H
    Chirurg; 2016 Aug; 87(8):698. PubMed ID: 27299751
    [No Abstract]   [Full Text] [Related]  

  • 8. Is radioiodine ablation necessary for patients with low-risk papillary thyroid carcinoma and tumor >4 cm?
    Rosario PW
    Eur J Surg Oncol; 2017 Sep; 43(9):1802-1803. PubMed ID: 28743373
    [No Abstract]   [Full Text] [Related]  

  • 9. Thyroglobulin-guided (131)I ablation in low-risk differentiated thyroid carcinoma: is the yardstick accurate enough?
    Giovanella L
    Head Neck; 2011 Sep; 33(9):1379-80; author reply 1380-1. PubMed ID: 21739512
    [No Abstract]   [Full Text] [Related]  

  • 10. Outcome after treatment of high-risk papillary and non-Hürthle-cell follicular thyroid carcinoma.
    Taylor T; Specker B; Robbins J; Sperling M; Ho M; Ain K; Bigos ST; Brierley J; Cooper D; Haugen B; Hay I; Hertzberg V; Klein I; Klein H; Ladenson P; Nishiyama R; Ross D; Sherman S; Maxon HR
    Ann Intern Med; 1998 Oct; 129(8):622-7. PubMed ID: 9786809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioiodine therapy of thyroid disease.
    Beierwaltes WH
    Int J Rad Appl Instrum B; 1987; 14(3):177-81. PubMed ID: 3312117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excellent prognosis of patients with solitary T1N0M0 papillary thyroid carcinoma who underwent thyroidectomy and elective lymph node dissection without radioiodine therapy.
    Ito Y; Masuoka H; Fukushima M; Inoue H; Kihara M; Tomoda C; Higashiyama T; Takamura Y; Kobayashi K; Miya A; Miyauchi A
    World J Surg; 2010 Jun; 34(6):1285-90. PubMed ID: 20041244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidental multifocal papillary microcarcinomas of the thyroid: is subtotal thyroidectomy combined with radioiodine ablation enough?
    Dietlein M; Luyken WA; Schicha H; Larena-Avellaneda A
    Nucl Med Commun; 2005 Jan; 26(1):3-8. PubMed ID: 15604941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment.
    Bonnet S; Hartl D; Leboulleux S; Baudin E; Lumbroso JD; Al Ghuzlan A; Chami L; Schlumberger M; Travagli JP
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1162-7. PubMed ID: 19116234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A vision for the surgical management of papillary thyroid carcinoma: extensive lymph node compartmental dissections and selective use of radioiodine.
    Mazzaferri EL
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1086-8. PubMed ID: 19349473
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapy of differentiated thyroid carcinomas. Prospective study].
    Gemsenjäger E; Staub JJ; Heitz PU
    Schweiz Med Wochenschr; 1985 Feb; 115(5):153-9. PubMed ID: 3975583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
    Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
    Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of total thyroidectomy with therapeutic central and lateral neck dissection with a single dose of radioiodine in the treatment of regionally advanced papillary thyroid cancer and effects on serum thyroglobulin.
    Hughes DT; Miller BS; Cohen MS; Doherty GM; Gauger PG
    Ann Surg Oncol; 2014 May; 21(5):1647-52. PubMed ID: 24385210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unusual case of radioactive iodine-induced Graves' disease with orbitopathy following total thyroidectomy in a patient with papillary thyroid microcarcinoma.
    Zgubieński K; Walczyk A; Kowalska A
    Endokrynol Pol; 2020; 71(3):277-278. PubMed ID: 32293702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The indications for ablating normal thyroid tissue with 131I in differentiated thyroid cancer.
    Goolden AW
    Clin Endocrinol (Oxf); 1985 Jul; 23(1):81-6. PubMed ID: 3896581
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.